Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis

The gut is a well-established route of infection and target for viral damage by SARS-CoV-2. This is supported by the clinical observation that about half of COVID-19 patients exhibit gastrointestinal (GI) complications. We aimed to investigate whether the analysis of plasma could provide insight int...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Ram, Patton, Michael John, Floyd, Jason Levi., Fortmann, Seth, DuPont, Mariana, Harbour, Angela, Wright, Justin, Lamendella, Regina, Stevens, Bruce R., Oudit, Gavin Y., Grant, Maria B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409329/
https://www.ncbi.nlm.nih.gov/pubmed/36012406
http://dx.doi.org/10.3390/ijms23169141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409329/
https://www.ncbi.nlm.nih.gov/pubmed/36012406
http://dx.doi.org/10.3390/ijms23169141

Ejemplares similares